GSK3B and kidney disorder: Some studies have used a lower dose of lithium chloride (30–80 mg/kg), by intraperitoneal injection, as an inhibitor of GSK-3β to treat renal diseases in LPS-induced or gentamicin-induced AKI model mouse models [6–8].